Kissei Pharmaceutical Co., Ltd. (4547.T)
JPY 3515.0
(0.14%)
JPY 3515.0
(0.14%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 11.16 Billion JPY | 6.0% |
| 2022 | 10.52 Billion JPY | -18.52% |
| 2021 | 12.92 Billion JPY | 144.48% |
| 2020 | 5.28 Billion JPY | 87.61% |
| 2019 | 2.81 Billion JPY | -48.6% |
| 2018 | 5.48 Billion JPY | -39.4% |
| 2017 | 9.04 Billion JPY | 17.07% |
| 2016 | 7.72 Billion JPY | -5.38% |
| 2015 | 8.16 Billion JPY | 13.96% |
| 2014 | 7.16 Billion JPY | -21.2% |
| 2013 | 9.09 Billion JPY | 81.17% |
| 2012 | 5.01 Billion JPY | 5.24% |
| 2011 | 4.76 Billion JPY | 19.11% |
| 2010 | 4 Billion JPY | -8.4% |
| 2009 | 4.37 Billion JPY | 112.08% |
| 2008 | 2.06 Billion JPY | -11.35% |
| 2007 | 2.32 Billion JPY | 47.99% |
| 2006 | 1.57 Billion JPY | -23.18% |
| 2005 | 2.04 Billion JPY | -56.8% |
| 2004 | 4.73 Billion JPY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 1.14 Billion JPY | -72.14% |
| 2024 Q1 | 4.1 Billion JPY | 45.45% |
| 2023 Q2 | 2.41 Billion JPY | -26.09% |
| 2023 Q1 | 3.26 Billion JPY | -15.44% |
| 2023 FY | 11.16 Billion JPY | 6.0% |
| 2023 Q3 | 2.65 Billion JPY | 10.19% |
| 2023 Q4 | 2.82 Billion JPY | 6.17% |
| 2022 Q1 | 1.63 Billion JPY | -73.21% |
| 2022 FY | 10.52 Billion JPY | -18.52% |
| 2022 Q2 | 1.69 Billion JPY | 3.43% |
| 2022 Q3 | 3.34 Billion JPY | 97.58% |
| 2022 Q4 | 3.86 Billion JPY | 15.56% |
| 2021 Q2 | 2.02 Billion JPY | -44.51% |
| 2021 Q3 | 1.15 Billion JPY | -42.98% |
| 2021 FY | 12.92 Billion JPY | 144.48% |
| 2021 Q4 | 6.1 Billion JPY | 429.23% |
| 2021 Q1 | 3.64 Billion JPY | 415.5% |
| 2020 Q1 | 1.72 Billion JPY | 337.93% |
| 2020 Q3 | 2.04 Billion JPY | -23.47% |
| 2020 FY | 5.28 Billion JPY | 87.61% |
| 2020 Q4 | -1.15 Billion JPY | -156.51% |
| 2020 Q2 | 2.67 Billion JPY | 54.84% |
| 2019 Q1 | 2.01 Billion JPY | 66.14% |
| 2019 Q4 | -725 Million JPY | -152.08% |
| 2019 Q3 | 1.39 Billion JPY | 908.7% |
| 2019 FY | 2.81 Billion JPY | -48.6% |
| 2019 Q2 | 138 Million JPY | -93.14% |
| 2018 FY | 5.48 Billion JPY | -39.4% |
| 2018 Q3 | 933 Million JPY | 56.54% |
| 2018 Q4 | 1.21 Billion JPY | 29.8% |
| 2018 Q1 | 2.74 Billion JPY | 176.03% |
| 2018 Q2 | 596 Million JPY | -78.26% |
| 2017 FY | 9.04 Billion JPY | 17.07% |
| 2017 Q4 | 993 Million JPY | -73.67% |
| 2017 Q3 | 3.77 Billion JPY | 73.11% |
| 2017 Q2 | 2.17 Billion JPY | 3.71% |
| 2017 Q1 | 2.1 Billion JPY | 207.61% |
| 2016 FY | 7.72 Billion JPY | -5.38% |
| 2016 Q1 | 2.83 Billion JPY | 541.43% |
| 2016 Q2 | 1.05 Billion JPY | -62.74% |
| 2016 Q3 | 3.15 Billion JPY | 198.58% |
| 2016 Q4 | 683 Million JPY | -78.34% |
| 2015 Q1 | 2.26 Billion JPY | 891.96% |
| 2015 Q3 | 4.86 Billion JPY | 188.94% |
| 2015 Q2 | 1.68 Billion JPY | -25.74% |
| 2015 Q4 | -642 Million JPY | -113.21% |
| 2015 FY | 8.16 Billion JPY | 13.96% |
| 2014 Q1 | 2.26 Billion JPY | 500.26% |
| 2014 FY | 7.16 Billion JPY | -21.2% |
| 2014 Q4 | -286 Million JPY | -109.7% |
| 2014 Q3 | 2.94 Billion JPY | 31.86% |
| 2014 Q2 | 2.23 Billion JPY | -1.5% |
| 2013 Q4 | 378 Million JPY | -92.34% |
| 2013 FY | 9.09 Billion JPY | 81.17% |
| 2013 Q1 | 2.42 Billion JPY | 273.38% |
| 2013 Q2 | 1.35 Billion JPY | -44.25% |
| 2013 Q3 | 4.93 Billion JPY | 264.75% |
| 2012 Q3 | 2.55 Billion JPY | 582.35% |
| 2012 FY | 5.01 Billion JPY | 5.24% |
| 2012 Q2 | 374 Million JPY | -74.08% |
| 2012 Q1 | 1.44 Billion JPY | 77.49% |
| 2012 Q4 | 650 Million JPY | -74.53% |
| 2011 Q1 | 1.33 Billion JPY | 78.27% |
| 2011 FY | 4.76 Billion JPY | 19.11% |
| 2011 Q2 | 1.13 Billion JPY | -15.18% |
| 2011 Q3 | 1.48 Billion JPY | 30.95% |
| 2011 Q4 | 813 Million JPY | -45.25% |
| 2010 Q4 | 750 Million JPY | -58.45% |
| 2010 Q1 | 1.24 Billion JPY | 650.6% |
| 2010 FY | 4 Billion JPY | -8.4% |
| 2010 Q2 | 202 Million JPY | -83.79% |
| 2010 Q3 | 1.8 Billion JPY | 793.56% |
| 2009 Q2 | 1.17 Billion JPY | -5.18% |
| 2009 Q4 | 166 Million JPY | -90.77% |
| 2009 Q3 | 1.79 Billion JPY | 53.54% |
| 2009 Q1 | 1.23 Billion JPY | 385.88% |
| 2009 FY | 4.37 Billion JPY | 112.08% |
| 2008 Q2 | 75 Million JPY | 0.0% |
| 2008 FY | 2.06 Billion JPY | -11.35% |
| 2008 Q3 | 936 Million JPY | 1148.0% |
| 2008 Q4 | -432 Million JPY | -146.15% |
| 2007 FY | 2.32 Billion JPY | 47.99% |
| 2006 FY | 1.57 Billion JPY | -23.18% |
| 2005 FY | 2.04 Billion JPY | -56.8% |
| 2004 FY | 4.73 Billion JPY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 3.2 Billion JPY | -248.206% |
| Takeda Pharmaceutical Company Limited | 144.06 Billion JPY | 92.254% |
| Sumitomo Pharma Co., Ltd. | -314.96 Billion JPY | 103.543% |
| Shionogi & Co., Ltd. | 162.03 Billion JPY | 93.112% |
| Wakamoto Pharmaceutical Co.,Ltd. | 108.95 Million JPY | -10142.385% |
| Nippon Shinyaku Co., Ltd. | 25.85 Billion JPY | 56.83% |
| Kaken Pharmaceutical Co., Ltd. | 8.02 Billion JPY | -39.065% |
| Eisai Co., Ltd. | 42.4 Billion JPY | 73.684% |
| Morishita Jintan Co., Ltd. | 697 Million JPY | -1501.148% |
| Hisamitsu Pharmaceutical Co., Inc. | 13.96 Billion JPY | 20.109% |
| Mochida Pharmaceutical Co., Ltd. | 4.54 Billion JPY | -145.437% |
| Fuso Pharmaceutical Industries,Ltd. | 1.37 Billion JPY | -710.458% |
| Nippon Chemiphar Co., Ltd. | -180 Million JPY | 6300.0% |
| Tsumura & Co. | 16.7 Billion JPY | 33.202% |
| Torii Pharmaceutical Co., Ltd. | 4.11 Billion JPY | -170.94% |
| Towa Pharmaceutical Co., Ltd. | 16.17 Billion JPY | 30.996% |
| Fuji Pharma Co., Ltd. | 3.43 Billion JPY | -224.891% |
| Zeria Pharmaceutical Co., Ltd. | 7.73 Billion JPY | -44.349% |
| KYORIN Holdings, Inc. | 5.32 Billion JPY | -109.696% |
| Taiko Pharmaceutical Co.,Ltd. | -4.89 Billion JPY | 328.034% |
| Daito Pharmaceutical Co.,Ltd. | 3.29 Billion JPY | -238.695% |
| SymBio Pharmaceuticals Limited | -1.96 Billion JPY | 668.571% |
| MedRx Co., Ltd | -932 Million JPY | 1297.425% |
| Mizuho Medy Co.,Ltd. | 3.77 Billion JPY | -195.689% |
| Solasia Pharma K.K. | -1.11 Billion JPY | 1103.597% |
| Modalis Therapeutics Corporation | -2.39 Billion JPY | 566.59% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 7.54 Billion JPY | -47.913% |
| Sawai Group Holdings Co., Ltd. | 13.69 Billion JPY | 18.51% |
| Cyfuse Biomedical K.K. | -589.21 Million JPY | 1994.058% |
| Toho Holdings Co., Ltd. | 20.65 Billion JPY | 45.975% |
| Koa Shoji Holdings Co.,Ltd. | 2.94 Billion JPY | -278.775% |